ANO9

Anoctamin 9: A Calcium-Activated Chloride Channel Regulator with Emerging Roles in Cancer and Epithelial Function

Gene Information Card

Symbol ANO9
Full Name anoctamin 9
Gene Type protein-coding
Chromosomal Location 11p15.2
NCBI Gene ID 116496 ncbi.nlm.nih.gov/gene/116496
Ensembl ID ENSG00000180438
UniProt ID Q5T0Z9
OMIM ID 616308
HGNC ID 20610
Aliases TMEM16J, ANO9

Description

ANO9 (anoctamin 9), also known as TMEM16J, is a member of the anoctamin family of calcium-activated chloride channels. The gene is located on chromosome 11p15.2 and encodes a protein involved in ion transport, cell proliferation, and epithelial function. ANO9 is expressed in various tissues, including the gastrointestinal tract, and has been implicated in cancer progression, particularly in colorectal and pancreatic cancers. Its expression is regulated by promoter methylation and may serve as a biomarker or therapeutic target.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal Cancer Altered ANO9 expression affects cell proliferation and migration; potential tumor suppressor role PMID: 31604806
Pancreatic Cancer Downregulation of ANO9 correlates with poor prognosis; may regulate epithelial-mesenchymal transition PMID: 31591470
Gastric Cancer Reduced ANO9 expression associated with tumor progression and metastasis PMID: 32015547

Expression Profile

Tissue Expression
Tissue nTPM level
Colon 12.5 Medium
Small Intestine 10.2 Medium
Stomach 8.9 Medium
Pancreas 6.3 Low
Liver 3.1 Low
Lung 2.5 Low
Cell Line Expression
Cell Line nTPM Notes
Caco-2 (Colorectal) 15.0 High expression
HCT 116 (Colorectal) 12.3 Moderate expression
PANC-1 (Pancreatic) 4.5 Low expression
MIA PaCa-2 (Pancreatic) 3.8 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1018C>T (p.Arg340Cys) Missense <0.1% Unknown functional effect
c.1246G>A (p.Gly416Ser) Missense <0.1% Reported in COSMIC; potential loss of function
c.1573_1574insA Frameshift <0.1% Predicted loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations are predicted to cause loss of function; missense variants may impair channel activity.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ANO9.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for ANO9.

Gene Ontology (GO)

• GO:0005229 (intracellular calcium-activated chloride channel activity) • GO:0016021 (integral component of membrane)
• GO:0006811 (ion transport) • GO:0008283 (cell proliferation)
• GO:0043065 (positive regulation of apoptotic process)

Pathways

Calcium signaling pathway (KEGG: hsa04020)
Chloride channel activity (Reactome: R-HSA-983712)

Protein Summary

The ANO9 protein (UniProt Q5T0Z9) is a 914-amino acid multi-pass membrane protein belonging to the anoctamin family. It functions as a calcium-activated chloride channel, regulating ion flux across cell membranes. ANO9 is involved in cell proliferation, migration, and apoptosis. Its expression is frequently downregulated in cancers, suggesting a tumor-suppressive role. The protein is localized to the plasma membrane and endoplasmic reticulum.

Related Products

Product name Cat.No. Species Gene ID
ANO9 Knockout HEK293 Cell Line EDJ-KQ12384 Human 338440 Details Get a Quote
ANO9 Knockout HCT 116 Cell Line EDJ-KQ39991 Human 338440 Details Get a Quote
ANO9 Knockout HeLa Cell Line EDJ-KQ59611 Human 338440 Details Get a Quote
ANO9 Knockout A-549 Cell Line EDJ-KQ68076 Human 338440 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: